Additionally, NDC-011, a novel drug combination developed through DR.NOAH's AI-based drug discovery platform, received Orphan Drug Designation (ODD) from the U.S. FDA in 2023 and IND approval for a ...
Investing in AI stocks could be the key to capitalizing on the next transformative technological wave. They can generate long term gains.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback